Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
What does drug selectivity depend on?
|
-Dose
-Drug Distribution -Receptor Distribution -Receptor Selectivity (specificity) |
|
What are the major types of receptors?
|
-Tyrosine Kinase linked receptors
-G protein linked receptors -Ligand Gated ion channel receptors -Intracellular receptors |
|
Give examples of Tyrosine Kinase Receptors?
|
-Insulin, EGF, GH, PDGF, VEGF
|
|
Give examples of G protein linked receptors?
|
-Serotonin, MUSCARINE, Dopaminergic, Noradrenergic
|
|
Give examples of ligand gated ion channel receptors?
|
-NICOTINIC, GABA, Glutamate
|
|
What mediates the actions of pharmacologic antagonists?
|
Receptors
|
|
What binds to a receptor but does not activate it?
|
Antagonist
|
|
What binds to a receptor, does not activate it, and is concentration dependent?
|
Competitive antagonist
|
|
In the presence of a competitive antagonist, _____ concentrations of an agonist are required to produce the same effect of agonist alone.
|
HIGHER
|
|
What changes the receptor to decrease efficacy of the agonist?
|
Noncompetitive Antagonist
|
|
What causes the same effect as eliminating a fraction of total receptors from the response?
|
Noncompetitive Antagonist
|
|
Is the Potency of noncompetitive antagonists dependent or independent of dose and relative affinity of the agonist?
|
INDEPENDENT
|
|
What binds covalently to a receptor, which causes the duration of the action to be the rate of turnover of the receptor molecules?
|
Irreversible Antagonists
|
|
What is the difference between Ligand specificity and affinity?
|
-Specificity: ligand binding to specific receptors
-Affinity: The extent to which the ligand is capable of binding and remains bound to a receptor |
|
What is intrinsic activity?
|
-The extent to which a bound ligand activates a receptor
-This distinguishes agonist from antagonist -(Receptor efficacy) |
|
What will an Agonist have?
|
Affinity and Activity
|
|
What will an Antagonist have?
|
Only Affinity, NO Activity
|
|
What does the Vmax value represent?
|
Max velocity due to saturatability
|
|
What does Km equal?
|
-The concentration of substrate needed to reach 1/2 Vmax
-Essentially a measure of affinity for the substrate |
|
What does Kd equal?
|
THe concentration at which BINDING is half saturated
|
|
What is Potency related to?
|
Drug Binding Affinity
|
|
What is Efficacy related to?
|
The Rate and Extent of receptor activation AFTER drug binding
|
|
In a "system", drug response increases _____ with dose?
|
Proportionally
|
|
______ is related to affinity for the receptor.
|
Potency
|
|
What does Emax represent?
|
Maximal response that can be produced (EFFICACY!!!)
|
|
What does EC50 represent?
|
The CONCENTRATION that produces 50% of the maximal effect (POTENCY!!!!!)
|
|
If Kd is low, then binding affinity is ____?
|
High
|
|
Drugs that produce a FULL effect on a system are called?
|
Full Agonists
|
|
Drugs that interact with a receptor but cannot produce the same maximal effect are called?
|
Partial agonists
|
|
What determines potency?
|
Affinity and Efficacy
|
|
What are the 3 types of Antagonism?
|
-Chemical
-Pharmacological -Physiological |
|
Describe a Chemical antagonist?
|
-Does NOT require a receptor
-It is a Chemical interaction of two substances |
|
Describe a Pharmacological antagonist?
|
-Binds to receptors, but does NOT activate signal transduction mechanism
-Prevents Agonist binding! |
|
Describe Physiological antagonists?
|
-Opposing effects by 2 agonists
-Ex. Insulin and GLucagon |
|
Are Pharmacological antagonists competitive?
|
Yes, they effect potency and can be both reversible or irreversible
|
|
What is an advantage of an irreversible inhibitor?
|
Its duration of action is dependent on the rate of TURNOVER!!!! (NOT elimination)
|
|
What is a disadvantage of an irreversible inhibitor?
|
Easier to overdose!
|
|
What do non-competitive Pharmacological antagonists primarily effect?
|
Efficacy! (downward shift in curve)
-Binds to a different site then the agonist |
|
Can you compete off a non-competitive Pharmacological antagonists?
|
No!!!!
|
|
How do you stop the effect of a non-competitive Pharmacological antagonists?
|
-Take the patient off the drug, this shift in concentration will shift the drug off its binding site!!
|
|
What allows an increase in sensitivity of target cells to activation by low levels of ligand?
|
SPARE RECEPTORS!!
|
|
In a system with NO spare receptors, is ED50 <, >, or = Kd?
|
(=) Equal to
|
|
What effect do spare receptors have on noncompetitive antagonists?
|
-Decrease their initial effect!
-They will function as "competitive" antagonists |